Wilmington Funds Management’s West Pharmaceutical WST Stock Holding History

Wilmington Funds Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$5.27M	Buy	124,930 +12,480	+11%	+$534K	0.53%	55
2014 Q1	$4.95M	Sell	112,450 -3,831	-3%	-$180K	0.54%	57
2013 Q4	$5.71M	Sell	116,281 -1,749	-1%	-$81.8K	0.57%	40
2013 Q3	$4.86M	Buy	118,030 +29,940	+34%	+$1.14M	0.47%	58
2013 Q2	$3.1M	Buy	+88,090	New	+$2.9M	0.29%	114

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wilmington Funds Management's WST Position: Q2 2014 in Review

Wilmington Funds Management increased its West Pharmaceutical (WST) stake by 11% in Q2 2014, buying an estimated $534K and bringing the position to 124,930 shares worth $5.27M. The position accounts for 0.53% of the portfolio, ranked #55.

Wilmington Funds Management first reported a position in WST in Q2 2013 and has held it in 5 quarters since. The position peaked at $5.71M in Q4 2013. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

Wilmington Funds Management held 124,930 shares of West Pharmaceutical worth $5.27M as of Q2 2014.
Wilmington Funds Management bought 12,480 West Pharmaceutical shares in Q2 2014, an estimated $534K.
West Pharmaceutical made up 0.53% of Wilmington Funds Management's portfolio in Q2 2014, its #55 holding.
Wilmington Funds Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 5 quarters since.
Wilmington Funds Management's West Pharmaceutical position peaked at $5.71M in Q4 2013.
222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.